Abstract
Interleukin-10 (IL-10) is a multifunctional cytokine with both immunosuppressive and anti-angiogenic functions and may have both tumour-promoting and -inhibiting properties. A large number of polymorphisms (primarily single nucleotide polymorphisms (SNPs)) have been identified in the IL-10 gene promoter. Convincing evidence that certain of these polymorphisms are associated with differential expression of IL-10 in vitro and in some cases in vivo has been obtained and a number of studies have investigated associations between IL-10 polymorphisms and cancer susceptibility/prognosis. The results from 22 studies in 13 different malignancies are reviewed. In 17 of these studies, positive associations between IL-10 genotype or haplotype and disease susceptibility and/or progression were reported. In some of these cancers genotypes associated with low IL-10 expression were a risk factor for disease or disease progression, while in others genotypes associated with high IL-10 expression were a risk factor. Published findings in breast cancer are as yet conflicting. Most, but not all of the studies reviewed are based on small sample sizes and a limited number of IL-10 polymorphisms. However, the preliminary data obtained thus far indicate that larger studies are required in a number of cancers, in order to confirm initial results, extend studies to include more detailed genotype/haplotype analysis and combine genotype and gene expression studies in the same subjects. Such studies will contribute significantly to our understanding of the biological role of IL-10 in cancer development.
Similar content being viewed by others
Abbreviations
- HLA:
-
human leukocyte antigen
- IL:
-
interleukin
- LTA:
-
lymphotoxin alpha
- NHL:
-
Non-Hodgkin’s lymphoma
- SNP:
-
single nucleotide polymorphism
- TGFB:
-
transforming growth factor beta
- TNFA:
-
tumour necrosis factor
References
Y Miki J Swensen D Shattuck-Eidens et al. (1994) ArticleTitleA strong candidate for the breast and ovarian cancer susceptibility gene BRCA1 Science 266 66–71 Occurrence Handle7545954 Occurrence Handle1:CAS:528:DyaK2MXhtF2ns70%3D
R Wooster G Bignell J Lancaster et al. (1995) ArticleTitleIdentification of the breast cancer susceptibility gene BRCA2 Nature 378 789–92 Occurrence Handle8524414 Occurrence Handle1:CAS:528:DyaK28XltFWi Occurrence Handle10.1038/378789a0
MA Blackwood BL. Weber (1998) ArticleTitleBRCA1 and BRCA2: from molecular genetics to clinical medicine J Clin Oncol 16 1969–77 Occurrence Handle9586917 Occurrence Handle1:CAS:528:DyaK1cXjtFOqt7o%3D
JR Smith D Freije JD Carpten et al. (1996) ArticleTitleMajor susceptibility locus for prostate cancer on chromosome 1 suggested by a genome-wide search Science 274 1371–4 Occurrence Handle8910276 Occurrence Handle1:CAS:528:DyaK28XntFKlsr0%3D Occurrence Handle10.1126/science.274.5291.1371
J Xu D Meyers D Freije S Isaccs et al. (1998) ArticleTitleEvidence for a prostate cancer susceptibility locus on the X chromosome Nat Genet 20 175–9 Occurrence Handle9771711 Occurrence Handle1:CAS:528:DyaK1cXms1aqtrw%3D Occurrence Handle10.1038/2477
D Ford DF Easton DT Bishop SA Narod DE Goldger (1994) ArticleTitleRisk of cancer in BRCA1 mutation carriers Lancet 343 692–5 Occurrence Handle7907678 Occurrence Handle1:STN:280:ByuC1c%2FmtFM%3D Occurrence Handle10.1016/S0140-6736(94)91578-4
M Gibbs JL Stanford RA McIndoe et al. (1999) ArticleTitleEvidence for a rare prostate cancer-susceptibility locus at chromosome 1p36 Am J Hum Genet 64 776–87 Occurrence Handle10053012 Occurrence Handle1:CAS:528:DyaK1MXitFCht7k%3D Occurrence Handle10.1086/302287
P Berthon A Valeri A Cohen-Akenine et al. (1998) ArticleTitlePredisposing gene for early-onset prostate cancer, localized on chromosome 1q42.2–43 Am J Hum Genet 62 1416–24 Occurrence Handle9585607 Occurrence Handle1:CAS:528:DyaK1cXlslCiu7o%3D Occurrence Handle10.1086/301879
SV Tavtigian J Simard DH Teng et al. (2001) ArticleTitleA strong candidate prostate cancer susceptibility gene at chromosome 17p Nat Genet 27 172–80 Occurrence Handle11175785 Occurrence Handle1:CAS:528:DC%2BD3MXhtFGktLc%3D Occurrence Handle10.1038/84808
K Nathanson BL Weber (2001) ArticleTitle“Other” breast cancer susceptibility genes: searching for more holy grail Hum Mol Genet 10 715–20 Occurrence Handle11257104 Occurrence Handle1:CAS:528:DC%2BD3MXjt1ajsbw%3D Occurrence Handle10.1093/hmg/10.7.715
PD Pharoah A Antoniou M Bobrow RL Zimmern DF Easton BA Ponder (2002) ArticleTitlePolygenic susceptibility to breast cancer and implications for prevention Nat Genet 31 33–6 Occurrence Handle11984562 Occurrence Handle1:CAS:528:DC%2BD38Xjt1Kgu7g%3D Occurrence Handle10.1038/ng853
R Wooster G Bignell J Lancaster et al. (1995) ArticleTitleIdentification of the breast cancer susceptibility gene BRCA2 Nature 378 789–92 Occurrence Handle8524414 Occurrence Handle1:CAS:528:DyaK28XltFWi Occurrence Handle10.1038/378789a0
J Charrier CM Maugard B LeMevel YJ Bignon (1999) ArticleTitleAllelotype influence at glutathione S-transferase M1 locus on breast cancer susceptibility Br J Cancer 79 346–53 Occurrence Handle9888479 Occurrence Handle1:CAS:528:DyaK1MXmvFeguw%3D%3D
M Bergman-Jungestrom M Gentile A Lundin (1999) ArticleTitleThe South East Breast Cancer Group, Wingren S. Association between CYP17 gene polymorphism and risk of breast cancer in young women Int J Cancer 84 350–3 Occurrence Handle10404084 Occurrence Handle1:CAS:528:DyaK1MXkvFansrc%3D Occurrence Handle10.1002/(SICI)1097-0215(19990820)84:4<350::AID-IJC3>3.0.CO;2-L
AM Dunning CS Healey PDP Pharaoh MD Teare BAJ Ponder DF Easton (1999) ArticleTitleA systematic review of genetic polymorphisms and breast cancer risk Cancer Epidemiol Biomark Prev 8 843–54 Occurrence Handle1:CAS:528:DyaK1MXns1CrtLw%3D
AC Bateman WM Howell (1999) ArticleTitleHuman leukocyte antigens and cancer: is it in our genes? J Pathol 188 231–6 Occurrence Handle10419588 Occurrence Handle1:CAS:528:DyaK1MXltVKrtbc%3D Occurrence Handle10.1002/(SICI)1096-9896(199907)188:3<231::AID-PATH325>3.0.CO;2-A
J Bidwell L Keen G Gallagher et al. (1999) ArticleTitleCytokine gene polymorphism in human disease: on-line databases Genes Immun 1 3–19 Occurrence Handle11197303 Occurrence Handle1:CAS:528:DC%2BD3cXktlyiurk%3D Occurrence Handle10.1038/sj.gene.6363645
Haukim N, Bidwell JL, Smith AJP, et al. Cytokine gene polymorphism in human disease: on-line databases, Supplement 2. Genes Immun 2002; 313–30
J Demeter F Porzsolt S Ramisch et al. (1997) ArticleTitlePolymorphism of the␣tumour necrosis factor-alpha and Lymphotoxin-alpha genes in chronic lymphocytic leukaemia Br J Haematol 97 107–12 Occurrence Handle9136948 Occurrence Handle1:STN:280:ByiB1c3mtl0%3D Occurrence Handle10.1046/j.1365-2141.1997.9912636.x
K Warzocha P Ribeiro J Bienvenu et al. (1998) ArticleTitleGenetic polymorphisms in the tumour necrosis factor locus influence non-Hodgkin;s lymphoma outcome Blood 91 3574–81 Occurrence Handle9572991 Occurrence Handle1:CAS:528:DyaK1cXjtFersro%3D
S Mestiri N Bouaouina SB Ahmed et al. (2001) ArticleTitleGenetic variation in the tumour necrosis factor-α promoter region and in the stress protein hsp70–2 Cancer 91 672–8 Occurrence Handle11241233 Occurrence Handle1:CAS:528:DC%2BD3MXhsFCrt7c%3D Occurrence Handle10.1002/1097-0142(20010215)91:4<672::AID-CNCR1050>3.0.CO;2-J
C Wihlborg J Sjoberg M Intaglietta et al. (1999) ArticleTitleTumour necrosis factor-α cytokine promoter polymorphism in Hodgkin’s disease and chronic lymphocytic leukaemia Br J Haematol 104 346–9 Occurrence Handle10050718 Occurrence Handle1:CAS:528:DyaK1MXhsV2gtr4%3D Occurrence Handle10.1046/j.1365-2141.1999.01176.x
KS Park JW Mok HE Ko et al. (2002) ArticleTitlePolymorphisms of tumour necrosis factors A and B in breast cancer Eur J Immunogenet 29 7–10 Occurrence Handle11841482 Occurrence Handle1:CAS:528:DC%2BD38Xit1Wltb8%3D Occurrence Handle10.1046/j.0960-7420.2001.00260.x
EM El-Omar M Carrington WH Chow et al. (2000) ArticleTitleInterleukin-1 polymorphisms associated with increased risk of gastric cancer Nature 404 398–402 Occurrence Handle10746728 Occurrence Handle1:CAS:528:DC%2BD3cXitlyltb4%3D Occurrence Handle10.1038/35006081
J Eskdale D Kube H Tesch G Gallagher (1997) ArticleTitleMapping of the human IL-10 gene and further characterisation of the 5′ flanking sequence Immunogenetics 46 120–8 Occurrence Handle9162098 Occurrence Handle1:CAS:528:DyaK2sXkslaiur8%3D Occurrence Handle10.1007/s002510050250
Howell WM. Interleukin-10 gene polymorphisms and cancer. In Marincola FM, (ed): Interleukin-10. Eurekah.com; pp. 1–17
DM Turner DM Williams D Sankaran M Lazarus PJ Sinnott IV Hutchinson (1997) ArticleTitleAn investigation of polymorphism in the Interleukin-10 gene promoter Eur J Immunogenetics 24 1–8 Occurrence Handle1:CAS:528:DyaK2sXhsFCjsL0%3D
E Crawley R Kay J Sillibourne P Patel I Hutchinson P Woo (1999) ArticleTitlepolymorphic haplotypes of the interleukin-10 5′ flanking region determine variable interleukin-10 transcription and are associated with particular phenotypes of juvenile rheumatoid arthritis Arthritis Rheum 42 1101–8 Occurrence Handle10366102 Occurrence Handle1:CAS:528:DyaK1MXktVegt70%3D Occurrence Handle10.1002/1529-0131(199906)42:6<1101::AID-ANR6>3.0.CO;2-Y
SC Hoffman EM Stanley ED Cox et al. (2001) ArticleTitleAssociation of cytokine polymorphic inheritance and in vitro cytokine production in anti-CD3/CD28-stimulated peripheral blood lymphocytes Transplantation 72 1444–50 Occurrence Handle10.1097/00007890-200110270-00019
E Reuss R Fimmers A Kruger C Becker C Rittner T Hohler (2002) ArticleTitleDifferential regulation of Interleukin-10 production by genetic and environmental factors: a twin study Genes Immun 3 407–13 Occurrence Handle12424622 Occurrence Handle1:CAS:528:DC%2BD38XosFamurw%3D Occurrence Handle10.1038/sj.gene.6363920
J Eskdale G Gallagher CL Verweij V Keijsers RG Westendorp TW Huizinga (1998) ArticleTitleInterleukin 10 secretion in relation to human IL-10 locus haplotypes Proc Natl Acad Sci USA 95 9465–70 Occurrence Handle9689103 Occurrence Handle1:CAS:528:DyaK1cXltlCls70%3D Occurrence Handle10.1073/pnas.95.16.9465
RG Westendorp JA Langermans TW Huizinga et al. (1997) ArticleTitleGenetic influence on cytokine production and fatal meningococcal disease Lancet 349 170–3 Occurrence Handle9111542 Occurrence Handle1:STN:280:ByiB28rmtlI%3D Occurrence Handle10.1016/S0140-6736(96)06413-6
WM Howell SJ Turner AC Bateman et al. (2001) ArticleTitleIL-10 promoter polymorphisms influence tumour development in cutaneous malignant melanoma Genes and Immun 2 25–31 Occurrence Handle1:CAS:528:DC%2BD3MXitV2ksL4%3D Occurrence Handle10.1038/sj.gene.6363726
JA Martinez-Escribano MR Moya-Quiles M Muro et al. (2002) ArticleTitleInterleukin-10, Interleukin-6 and interferon-γ gene polymorphisms in melanoma patients Melanoma Res 12 465–9 Occurrence Handle12394188 Occurrence Handle1:CAS:528:DC%2BD38XotVOisrk%3D Occurrence Handle10.1097/00008390-200209000-00008
SL McCarron S Edwards PR Evans et al. (2002) ArticleTitleInfluence of cytokine gene polymorphisms on the development of prostate cancer Cancer Res 62 3369–72 Occurrence Handle12067976 Occurrence Handle1:CAS:528:DC%2BD38XkslWqsLs%3D
KC Smith AC Bateman HM Fussell WM Howell (2004) ArticleTitleCytokine gene polymorphisms and breast cancer susceptibility and prognosis Eur J Immunogenet 31 167–73 Occurrence Handle15265021 Occurrence Handle1:CAS:528:DC%2BD2cXnsFSjsr8%3D Occurrence Handle10.1111/j.1365-2370.2004.00462.x
L Giordani P Bruzzi M Quaranta et al. (2004) ArticleTitlePolymorphisms of Interleukin-10 and tumour necrosis factor-α gene promoter and breast cancer risk Clin Chem 49 1664–7 Occurrence Handle10.1373/49.10.1664
U Langsenlehner P Krippl W Renner et al. (2005) ArticleTitleInterleukin-10 promoter polymorphism is associated with decreased breast cancer risk Breast Cancer Res Treat 90 113–5 Occurrence Handle15803357 Occurrence Handle1:CAS:528:DC%2BD2MXivVKhs74%3D Occurrence Handle10.1007/s10549-004-3607-7
EA Bulpitt C Baynes AM Dunning PR Evans DF Easton BAJ Ponder R Gibbs WM. Howell (2004) ArticleTitleInvestigation of Interleukin-10 and vascular endothelial growth factor single nucleotide polymorphisms in predisposition to breast cancer Genes Immun 5 IssueIDSuppl. 1 S53
GA Stanczuk EN Sibanda C Perrey et al. (2001) ArticleTitleCancer of the uterine cervix may be significantly associated with a gene polymorphism coding for increased IL-10 production Int J Cancer 94 792–4 Occurrence Handle11745479 Occurrence Handle1:CAS:528:DC%2BD3MXotFOkur0%3D Occurrence Handle10.1002/ijc.1543
JW Roh MH Kim SS Seo et al. (2002) ArticleTitleInterleukin-10 promoter polymorphisms and cervical cancer risk in Korean women Cancer Lett 184 57–63 Occurrence Handle12104048 Occurrence Handle1:CAS:528:DC%2BD38XkvFyktLo%3D Occurrence Handle10.1016/S0304-3835(02)00193-3
M-S Wu C-Y Wu C-J Chen et al. (2003) ArticleTitleInterleukin-10 genotypes associate with the risk of gastric carcinoma in Taiwanese Chinese Int J Cancer 104 617–23 Occurrence Handle12594817 Occurrence Handle1:CAS:528:DC%2BD3sXisVehtLo%3D Occurrence Handle10.1002/ijc.10987
M-S Wu S-P Huang Y-T Chang et al. (2002) ArticleTitleTumour necrosis factor-α and Interleukin-10 promoter polymorphisms in Epstein-Barr virus-associated gastric carcinoma J Infect Dis 185 106–9 Occurrence Handle11756988 Occurrence Handle1:CAS:528:DC%2BD38XmvFajuw%3D%3D Occurrence Handle10.1086/324771
EM El-Omar CS Rabkin MD Gammon et al. (2003) ArticleTitleIncreased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms Gastroenterology 124 1193–1201 Occurrence Handle12730860 Occurrence Handle1:CAS:528:DC%2BD3sXktVSktrw%3D Occurrence Handle10.1016/S0016-5085(03)00157-4
E Alamartine E Berthoux C Mariat et al. (2003) ArticleTitleInterleukin-10 promoter polymorphisms and susceptibility to skin squamous cell carcinoma after renal transplantation J Invest Dermatol 120 99–103 Occurrence Handle12535204 Occurrence Handle10.1046/j.1523-1747.2003.12016.x
HD Shin BL Park LH Kim et al. (2003) ArticleTitleInterleukin 10 haplotype associated with increased risk of hepatocellular carcinoma Hum Mol Genet 12 901–6 Occurrence Handle12668613 Occurrence Handle1:CAS:528:DC%2BD3sXjvVyktro%3D Occurrence Handle10.1093/hmg/ddg104
Havranek E, Howell WM, Fussell HM, Whelan JA, Whelan MA, Pandha HS. An IL-10 promoter polymorphism may influence tumour development in renal cell carinoma. J Urol 2005; 173: 709–12
C Zheng D Huang L Liu et al. (2001) ArticleTitleInterleukin-10 gene promoter polymorphisms in multiple myeloma Int J Cancer 95 184–8 Occurrence Handle11307152 Occurrence Handle1:CAS:528:DC%2BD3MXjvFOmtr8%3D Occurrence Handle10.1002/1097-0215(20010520)95:3<184::AID-IJC1031>3.0.CO;2-V
D Gowans A O’Sullivan S Rollison et al. (2002) ArticleTitleAllele and Haplotype frequency at human leucocyte antigen class I/II and immunomodulatory cytokine loci in patients with myelodysplasia and acute myeloid leukaemia: in search of an autoimmune aetiology Br J Haematol 117 541–5 Occurrence Handle12028020 Occurrence Handle1:CAS:528:DC%2BD38Xlt1Cqs7o%3D Occurrence Handle10.1046/j.1365-2141.2002.03452.x
LM Cunningham C Chapman R Dunstan et al. (2003) ArticleTitlePolymorphisms in the Interleukin 10 gene promoter are associated with susceptibility to aggressive non-Hodgkin’s lymphoma Leukemia Lymphoma 44 251–5 Occurrence Handle12688341 Occurrence Handle1:STN:280:DC%2BD3s7mvFyjtg%3D%3D Occurrence Handle10.1080/1042819021000035590
EC Breen WJ Boscardin R Detels et al. (2003) ArticleTitleNon-Hodgkin’s B cell lymphoma in persons with acquired immunodeficiency syndrome is associated with increased serum levels of IL-10, or the IL-10 promoter -592 C/C genotype Clin Immunol 109 119–29 Occurrence Handle14597210 Occurrence Handle1:CAS:528:DC%2BD3sXos1CjtL8%3D Occurrence Handle10.1016/S1521-6616(03)00214-6
E Lech-Maranda L Baseggio J Bienvenu et al. (2004) ArticleTitleInterleukin-10 gene promoter polymorphisms influence the clinical outcome of diffuse large B-cell lymphoma Blood 103 3529–34 Occurrence Handle14701701 Occurrence Handle1:CAS:528:DC%2BD2cXjslKgtLw%3D Occurrence Handle10.1182/blood-2003-06-1850
LR Munro PW Johnston NA Marshall et al. (2003) ArticleTitlePolymorphisms in the interleukin-10 and interferon gamma genes in Hodgkin lymphoma Leukemia & Lymphoma 44 2083–8 Occurrence Handle1:CAS:528:DC%2BD3sXosVGisbw%3D Occurrence Handle10.1080/1042819031000119316
M Lauten T Matthias M Stanulla et al. (2002) ArticleTitleAssociation of initial response to prednisone treatment in childhood acute leukaemia and polymorphism within the tumour necrosis factor and the Interleukin-10 gene Leukemia 16 1437–42 Occurrence Handle12145682 Occurrence Handle1:CAS:528:DC%2BD38Xls1WqsLw%3D Occurrence Handle10.1038/sj.leu.2402545
A DeMichele AM Martin R Mick et al. (2003) ArticleTitleInterleukin-6 –174 G→C polymorphism is associated with high risk breast cancer Cancer Res 15 8051–6
LS Ito H Iwata N Hamajima et al. (2002) ArticleTitleSignificant reduction in breast cancer risk for Japanese women with interleukin1B – 31CT/TT relative to CC genotype Jpn J Clin Oncol 32 398–402 Occurrence Handle12451035 Occurrence Handle10.1093/jjco/hyf081
A Saha V Gupta NK Bairwa D Malhotra R Bamezai (2004) ArticleTitleTransforming growth factor-bta1 genotype in sporadic breast cancer patients from India: status of enhancer, promoter, 5′-untranslated-region and exon-1 polymorphisms Eur J Immunogenet 31 37–42 Occurrence Handle15009180 Occurrence Handle1:CAS:528:DC%2BD2cXjtlGjtLw%3D Occurrence Handle10.1111/j.1365-2370.2004.00442.x
KM Lee SK Park N Hamajima et al. (2005) ArticleTitleGenetic polymorphisms of TGF-beta 1 and TNF-beta and breast cancer risk Breast Cancer Res Treat 90 149–55 Occurrence Handle15803361 Occurrence Handle1:CAS:528:DC%2BD2MXivVKhs70%3D Occurrence Handle10.1007/s10549-004-3859-2
AM Dunning PD Ellis S McBride et al. (2003) ArticleTitleA transforming growth factor beta 1 signal peptide variant increases secretion in vitro and is associated with increased incidence of invasive breast cancer Cancer Res 63 2610–5 Occurrence Handle12750287 Occurrence Handle1:CAS:528:DC%2BD3sXjsleht7w%3D
JH Barrett W Thomson W Ollier (2000) HLA and disease association: statistical considerations JL Bidwell C Navarrete (Eds) Histocompatibility Testing Imperial College Press London 439–452
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Howell, W.M., Rose-Zerilli, M.J. Interleukin-10 Polymorphisms, Cancer Susceptibility and Prognosis. Familial Cancer 5, 143–149 (2006). https://doi.org/10.1007/s10689-005-0072-3
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s10689-005-0072-3